We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current EMMA market cap is 137.28M. The company's latest EPS is USD -0.2144 and P/E is -12.92.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.94M | 5.93M | 6.75M | 10.76M | 5.02M |
| Operating Income | -1.09M | -1.84M | -1.69M | 2.89M | -357k |
| Net Income | -391k | 200k | -3.53M | -1.48M | 67k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.32M | 22.75M | 23.17M | 20.61M | 18.39M |
| Operating Income | -10.25M | -4.93M | -2.35M | -8.86M | -8.5M |
| Net Income | -9.6M | -54.84M | 1.1M | -15.95M | -10.63M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 42.2M | 48.23M | 48.95M | 50.29M | 47.45M |
| Total Liabilities | 79.79M | 82.32M | 84.9M | 85.32M | 83.78M |
| Total Equity | -37.59M | -34.09M | -35.95M | -35.03M | -36.33M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.15M | 59.46M | 59.28M | 56.73M | 48.23M |
| Total Liabilities | 1.87M | 70.51M | 64.69M | 78.18M | 82.32M |
| Total Equity | 3.29M | -11.05M | -5.42M | -21.45M | -34.09M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.75M | -5.07M | -1.29M | -2.6M | -2.54M |
| Investing | -1.33M | -2.39M | -1.09M | -27k | -426k |
| Financing | 7.06M | 7.23M | 2.14M | 1.99M | 2.48M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.04M | -4.52M | -2.45M | -1.25M | -5.07M |
| Investing | -361k | -1.48M | 5.47M | -6.38M | -2.39M |
| Financing | 7.21M | 3.88M | -2.31M | 7.41M | 7.23M |
| Market Cap | 137.28M |
| Price to Earnings Ratio | -12.92 |
| Price to Sales Ratio | 7.46 |
| Price to Cash Ratio | 67.89 |
| Price to Book Ratio | -4.03 |
| Dividend Yield | - |
| Shares Outstanding | 49.56M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.12 (4.18%) |
| Company Name | Emmaus Life Sciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.emmausmedical.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
